232 related articles for article (PubMed ID: 28283687)
1. Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.
Foer D; Zhu M; Cardone RL; Simpson C; Sullivan R; Nemiroff S; Lee G; Kibbey RG; Petersen KF; Insogna KL
Osteoporos Int; 2017 Jun; 28(6):2011-2017. PubMed ID: 28283687
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.
Simpson CA; Foer D; Lee GS; Bihuniak J; Sun B; Sullivan R; Belsky J; Insogna KL
Osteoporos Int; 2014 Oct; 25(10):2383-8. PubMed ID: 24927689
[TBL] [Abstract][Full Text] [Related]
3. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.
Lee GS; Simpson C; Sun BH; Yao C; Foer D; Sullivan B; Matthes S; Alenina N; Belsky J; Bader M; Insogna KL
J Bone Miner Res; 2014 Apr; 29(4):976-81. PubMed ID: 24038240
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion.
Fujino T; Asaba H; Kang MJ; Ikeda Y; Sone H; Takada S; Kim DH; Ioka RX; Ono M; Tomoyori H; Okubo M; Murase T; Kamataki A; Yamamoto J; Magoori K; Takahashi S; Miyamoto Y; Oishi H; Nose M; Okazaki M; Usui S; Imaizumi K; Yanagisawa M; Sakai J; Yamamoto TT
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):229-34. PubMed ID: 12509515
[TBL] [Abstract][Full Text] [Related]
5. Association of LRP5, TCF7L2, and GCG variants and type 2 diabetes mellitus as well as fasting plasma glucose and lipid metabolism indexes.
Wang J; Yan G; Zhang J; Gao K; Zhang M; Li L; Wang Y; Wang Q; Zhai Y; You H; Ren Y; Wang B; Hu D
Hum Immunol; 2015 May; 76(5):339-43. PubMed ID: 25863010
[TBL] [Abstract][Full Text] [Related]
6. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
[TBL] [Abstract][Full Text] [Related]
7. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of β cell function in a Chinese population with different glucose tolerance status.
Zhou M; Zhu L; Cui X; Feng L; Zhao X; He S; Ping F; Li W; Li Y
Lipids Health Dis; 2016 Jun; 15():104. PubMed ID: 27267043
[TBL] [Abstract][Full Text] [Related]
8. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
9. Reducing VEGFB expression regulates the balance of glucose and lipid metabolism in mice via VEGFR1.
Luo X; Li RR; Li YQ; Yu HP; Yu HN; Jiang WG; Li YN
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894135
[TBL] [Abstract][Full Text] [Related]
10. Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia.
Niziolek PJ; Bullock W; Warman ML; Robling AG
PLoS One; 2015; 10(11):e0140775. PubMed ID: 26554834
[TBL] [Abstract][Full Text] [Related]
11. Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism.
Kim SP; Frey JL; Li Z; Goh BC; Riddle RC
Endocrinology; 2017 Nov; 158(11):3805-3816. PubMed ID: 28938444
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride is independently correlated with insulin resistance and islet beta cell function: a study in population with different glucose and lipid metabolism states.
Ma M; Liu H; Yu J; He S; Li P; Ma C; Zhang H; Xu L; Ping F; Li W; Sun Q; Li Y
Lipids Health Dis; 2020 Jun; 19(1):121. PubMed ID: 32487177
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-Function Lrp5 Mutation Improves Bone Mass and Strength and Delays Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes.
Leanza G; Fontana F; Lee SY; Remedi MS; Schott C; Ferron M; Hamilton-Hall M; Alippe Y; Strollo R; Napoli N; Civitelli R
J Bone Miner Res; 2021 Jul; 36(7):1403-1415. PubMed ID: 33831261
[TBL] [Abstract][Full Text] [Related]
14. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
[TBL] [Abstract][Full Text] [Related]
15. Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.
Gregson CL; Poole KE; McCloskey EV; Duncan EL; Rittweger J; Fraser WD; Smith GD; Tobias JH
J Clin Endocrinol Metab; 2014 Aug; 99(8):2897-907. PubMed ID: 24606091
[TBL] [Abstract][Full Text] [Related]
16. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
[TBL] [Abstract][Full Text] [Related]
17. Effect of a Low-Fat Vegan Diet on Body Weight, Insulin Sensitivity, Postprandial Metabolism, and Intramyocellular and Hepatocellular Lipid Levels in Overweight Adults: A Randomized Clinical Trial.
Kahleova H; Petersen KF; Shulman GI; Alwarith J; Rembert E; Tura A; Hill M; Holubkov R; Barnard ND
JAMA Netw Open; 2020 Nov; 3(11):e2025454. PubMed ID: 33252690
[TBL] [Abstract][Full Text] [Related]
18. Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients.
Rui X; Xu B; Su J; Pan C; Zhan C; Su B; Li H; Wang J; Sheng H; Qu S
Med Sci Monit; 2014 May; 20():711-9. PubMed ID: 24785155
[TBL] [Abstract][Full Text] [Related]
19. A Study of the Relationship between the Polymorphism and Mutation of rs682429 and rs3781590 in the LRP5 Gene and Bone Metabolism in Postmenopausal Type 2 Diabetic Women in Xinjiang.
Li J; Li S; Zhao H; Li J; Wang S; Shi Y
J Diabetes Res; 2020; 2020():3071217. PubMed ID: 32405501
[TBL] [Abstract][Full Text] [Related]
20. High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo.
Niziolek PJ; MacDonald BT; Kedlaya R; Zhang M; Bellido T; He X; Warman ML; Robling AG
J Bone Miner Res; 2015 Oct; 30(10):1822-30. PubMed ID: 25808845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
